Literature DB >> 23804535

Potential role of tocotrienols in the treatment and prevention of breast cancer.

Paul W Sylvester1, Mohamed R Akl, Abhita Malaviya, Parash Parajuli, Suryatheja Ananthula, Roshan V Tiwari, Nehad M Ayoub.   

Abstract

Vitamin E is a generic term that refers to a family of compounds that is further divided into two subgroups called tocopherols and tocotrienols. Although all natural forms of vitamin E display potent antioxidant activity, tocotrienols are significantly more potent than tocopherols in inhibiting tumor cell growth and viability, and anticancer activity of tocotrienols is mediated independently of their antioxidant activity. In addition, the anticancer effects of tocotrienols are observed using treatment doses that have little or no effect on normal cell function or viability. This review will summarize experimental studies that have identified the intracellular mechanism mediating the anticancer effects of tocotrienols. Evidence is also provided showing that combined treatment of tocotrienol with other cancer chemotherapies can result in a synergistic inhibition in cancer cell growth and viability. Taken together, these findings strongly indicate that tocotrienols may provide significant health benefits in the prevention and/or treatment of cancer when used either alone as monotherapy or in combination with other anticancer agents.
© 2013 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  apoptosis; breast cancer; combination chemotherapy; signal transduction; tocotrienols

Mesh:

Substances:

Year:  2013        PMID: 23804535     DOI: 10.1002/biof.1116

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  9 in total

Review 1.  Utilization of Vitamin E Analogs to Protect Normal Tissues While Enhancing Antitumor Effects.

Authors:  Nukhet Aykin-Burns; Rupak Pathak; Marjan Boerma; Thomas Kim; Martin Hauer-Jensen
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

2.  γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.

Authors:  R A Ahmed; O A Alawin; P W Sylvester
Journal:  Cell Prolif       Date:  2016-06-21       Impact factor: 6.831

3.  Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.

Authors:  Roshan V Tiwari; Parash Parajuli; Paul W Sylvester
Journal:  Mol Cell Biochem       Date:  2015-06-27       Impact factor: 3.396

4.  Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.

Authors:  Yumi Jang; Xiayu Rao; Qing Jiang
Journal:  J Nutr Biochem       Date:  2017-04-12       Impact factor: 6.048

Review 5.  Revisiting the therapeutic potential of tocotrienol.

Authors:  Ranmali Ranasinghe; Michael Mathai; Anthony Zulli
Journal:  Biofactors       Date:  2022-06-20       Impact factor: 6.438

6.  Tocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β.

Authors:  Chuanhui Xun; Mardan Mamat; Hailong Guo; Pulat Mamati; Jun Sheng; Jian Zhang; Tao Xu; Weidong Liang; Rui Cao; Weibin Sheng
Journal:  Exp Ther Med       Date:  2017-05-23       Impact factor: 2.447

7.  Tocotrienols induce endoplasmic reticulum stress and apoptosis in cervical cancer cells.

Authors:  Raffaella Comitato; Barbara Guantario; Guido Leoni; Kalanithi Nesaretnam; Maria Beatrice Ronci; Raffaella Canali; Fabio Virgili
Journal:  Genes Nutr       Date:  2016-12-23       Impact factor: 5.523

Review 8.  Natural 6-hydroxy-chromanols and -chromenols: structural diversity, biosynthetic pathways and health implications.

Authors:  Marc Birringer; Karsten Siems; Alexander Maxones; Jan Frank; Stefan Lorkowski
Journal:  RSC Adv       Date:  2018-01-26       Impact factor: 4.036

9.  Beta-Tocotrienol Exhibits More Cytotoxic Effects than Gamma-Tocotrienol on Breast Cancer Cells by Promoting Apoptosis via a P53-Independent PI3-Kinase Dependent Pathway.

Authors:  Maya Idriss; Mohammad Hassan Hodroj; Rajaa Fakhoury; Sandra Rizk
Journal:  Biomolecules       Date:  2020-04-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.